Close

Aquestive Therapeutics Inc. (AQST) Reaffirms Near-Term NDA Resubmission for Libervant (diazepam) Buccal Film Following FDA Feedback

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/16/2024

1. SPY
2. TSLA
3. RDDT
4. TCS:IN
5. ALAB
6. JPM
7. C
8. AAPL
9. GS
10. DJT


Go back to Aquestive Therapeutics Inc. (AQST) Reaffirms Near-Term NDA Resubmission for Libervant (diazepam) Buccal Film Following FDA Feedback
(NASDAQ: AQST) Delayed: 3.94 +0.03 (0.77%)
Previous Close $3.91    52 Week High $ 
Open $4.05    52 Week Low $ 
Day High $4.10    P/E N/A 
Day Low $3.83    EPS $ 
Volume 1,343,964